Birchview Capital

Birchview Capital as of Dec. 31, 2015

Portfolio Holdings for Birchview Capital

Birchview Capital holds 40 positions in its portfolio as reported in the December 2015 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Celgene Corporation 53.5 $93M 776k 119.76
Accelr8 Technology 26.7 $46M 2.2M 21.49
Vermillion 2.8 $4.9M 2.7M 1.80
Metabolix 1.8 $3.1M 2.3M 1.39
Contrafect 1.3 $2.3M 475k 4.75
EQT Corporation (EQT) 1.3 $2.2M 42k 52.13
Collegium Pharmaceutical Inc Common Stock Usd (COLL) 0.9 $1.6M 59k 27.50
Medivation 0.9 $1.6M 33k 48.35
Masimo Corporation (MASI) 0.9 $1.5M 37k 41.50
Neurocrine Biosciences (NBIX) 0.8 $1.3M 23k 56.55
Oncomed Pharmaceuticals 0.8 $1.3M 59k 22.54
Hansen Medical 0.7 $1.2M 528k 2.33
Biolase Technology 0.6 $1.1M 1.3M 0.84
Quotient 0.5 $931k 58k 16.00
Kura Oncology (KURA) 0.5 $884k 105k 8.40
Quidel Corporation 0.5 $826k 39k 21.19
Merck & Co (MRK) 0.5 $792k 15k 52.80
Wright Medical 0.4 $725k 30k 24.17
Encana Corp 0.4 $673k 132k 5.09
Accuray Incorporated (ARAY) 0.4 $643k 95k 6.75
NxStage Medical 0.3 $563k 26k 21.91
Cerus Corporation (CERS) 0.3 $525k 83k 6.33
Ptc Therapeutics I (PTCT) 0.3 $483k 15k 32.42
Oxford Immunotec Global 0.3 $463k 40k 11.49
Corcept Therapeutics Incorporated (CORT) 0.2 $398k 80k 4.98
Gilead Sciences (GILD) 0.2 $387k 3.8k 101.31
Pioneer Natural Resources 0.2 $376k 3.0k 125.33
Sientra 0.2 $375k 63k 5.92
Cabot Oil & Gas Corporation (CTRA) 0.2 $371k 21k 17.67
Tesaro 0.2 $364k 7.0k 52.37
Advaxis 0.2 $358k 36k 10.06
Biogen Idec (BIIB) 0.2 $306k 1.0k 306.00
Transition Therapeutics 0.2 $280k 146k 1.92
Celgene Corp right 12/31/2011 0.2 $286k 238k 1.20
Merrimack Pharmaceuticals In 0.1 $237k 30k 7.90
Agios Pharmaceuticals (AGIO) 0.1 $221k 3.4k 65.00
Raptor Pharmaceutical 0.1 $208k 40k 5.20
Roka Bioscience 0.1 $187k 152k 1.23
Xencor (XNCR) 0.1 $180k 12k 14.63
Coherus Biosciences (CHRS) 0.1 $172k 7.5k 22.93